Metabolic Dysfunction and Altered Mitochondrial Dynamics in the Utrophin-Dystrophin Deficient Mouse Model of Duchenne Muscular Dystrophy

The utrophin-dystrophin deficient (DKO) mouse model has been widely used to understand the progression of Duchenne muscular dystrophy (DMD). However, it is unclear as to what extent muscle pathology affects metabolism. Therefore, the present study was focused on understanding energy expenditure in the whole animal and in isolated extensor digitorum longus (EDL) muscle and to determine changes in metabolic enzymes. Our results show that the 8 week-old DKO mice consume higher oxygen relative to activity levels. Interestingly the EDL muscle from DKO mouse consumes higher oxygen per unit integral force, generates less force and performs better in the presence of pyruvate thus mimicking a slow twitch muscle. We also found that the expression of hexokinase 1 and pyruvate kinase M2 was upregulated several fold suggesting increased glycolytic flux. Additionally, there is a dramatic increase in dynamin-related protein 1 (Drp 1) and mitofusin 2 protein levels suggesting increased mitochondrial fission and fusion, a feature associated with increased energy demand and altered mitochondrial dynamics. Collectively our studies point out that the dystrophic disease has caused significant changes in muscle metabolism. To meet the increased energetic demand, upregulation of metabolic enzymes and regulators of mitochondrial fusion and fission is observed in the dystrophic muscle. A better understanding of the metabolic demands and the accompanied alterations in the dystrophic muscle can help us design improved intervention therapies along with existing drug treatments for the DMD patients.

[1]  N. Chiamvimonvat,et al.  Ablation of sarcolipin enhances sarcoplasmic reticulum calcium transport and atrial contractility , 2007, Proceedings of the National Academy of Sciences.

[2]  J. Hawley,et al.  Signalling mechanisms in skeletal muscle: role in substrate selection and muscle adaptation. , 2006, Essays in biochemistry.

[3]  L. Guarente,et al.  Muscle-Specific SIRT1 Gain-of-Function Increases Slow-Twitch Fibers and Ameliorates Pathophysiology in a Mouse Model of Duchenne Muscular Dystrophy , 2014, PLoS genetics.

[4]  E A Barnard,et al.  The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. , 1989, Science.

[5]  J. Sowers,et al.  The metabolic syndrome: role of skeletal muscle metabolism. , 2006, Annals of medicine.

[6]  J. D. Porter,et al.  Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles , 2006, Neurogenetics.

[7]  Yaguang Si,et al.  Hormone-induced mitochondrial fission is utilized by brown adipocytes as an amplification pathway for energy expenditure , 2014, The EMBO journal.

[8]  J. Schneider,et al.  Increased sarcolipin expression and decreased sarco(endo)plasmic reticulum Ca2+ uptake in skeletal muscles of mouse models of Duchenne muscular dystrophy , 2013, Journal of Muscle Research and Cell Motility.

[9]  E. Ravussin,et al.  Skeletal muscle metabolism is a major determinant of resting energy expenditure. , 1990, The Journal of clinical investigation.

[10]  T. Gedrange,et al.  Increased oxidative stress in dystrophin deficient (mdx) mice masticatory muscles. , 2011, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[11]  Y. Adachi,et al.  In vivo functions of Drp1: lessons learned from yeast genetics and mouse knockouts. , 2014, Biochimica et biophysica acta.

[12]  D. Ellis,et al.  Isoenzymes of hexokinase in human muscular dystrophy , 1975, Nature.

[13]  C. Denis,et al.  Mitochondrial biogenesis during skeletal muscle regeneration. , 2002, American journal of physiology. Endocrinology and metabolism.

[14]  Jan Nedergaard,et al.  Nonshivering thermogenesis and its adequate measurement in metabolic studies , 2011, Journal of Experimental Biology.

[15]  S. John,et al.  Subcellular Localization of Hexokinases I and II Directs the Metabolic Fate of Glucose , 2011, PloS one.

[16]  I. Smith,et al.  ATP Consumption by Sarcoplasmic Reticulum Ca2+ Pumps Accounts for 40-50% of Resting Metabolic Rate in Mouse Fast and Slow Twitch Skeletal Muscle , 2013, PloS one.

[17]  P. Even,et al.  Defective regulation of energy metabolism in mdx-mouse skeletal muscles. , 1994, The Biochemical journal.

[18]  Cindy Hamil,et al.  Evidence‐based path to newborn screening for duchenne muscular dystrophy , 2012, Annals of neurology.

[19]  Susan C. Brown,et al.  Dystrophin and utrophin: Genetic analyses of their role in skeletal muscle , 2000, Microscopy research and technique.

[20]  M. Palacín,et al.  The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. , 2005, Human molecular genetics.

[21]  Marc Liesa,et al.  Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes. , 2009, The international journal of biochemistry & cell biology.

[22]  A. Zorzano.  Regulation of mitofusin-2 expression in skeletal muscle. , 2009, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[23]  K. Davies,et al.  Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping , 2012, Human molecular genetics.

[24]  K. Davies,et al.  Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  K. Flaherty,et al.  Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals , 2012, Nature Medicine.

[26]  J. Chamberlain,et al.  Dystrophin‐deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  I. Macdonald,et al.  The metabolic and cardiovascular effects of intravenous infusion of glucose or intralipid in normal humans. , 1989, Clinical nutrition.

[28]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[29]  L. Shapiro,et al.  Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in progressive muscular dystrophies , 1978, Journal of the Neurological Sciences.

[30]  R. Woledge,et al.  The effect of metabolic fuel on force production and resting inorganic phosphate levels in mouse skeletal muscle. , 1993, The Journal of physiology.

[31]  S. Matecki,et al.  Peroxisome proliferator‐activated receptor γ coactivator 1‐α gene transfer restores mitochondrial biomass and improves mitochondrial calcium handling in post‐necrotic mdx mouse skeletal muscle , 2012, The Journal of physiology.

[32]  A. Odermatt,et al.  Sarcolipin Regulates the Activity of SERCA1, the Fast-twitch Skeletal Muscle Sarcoplasmic Reticulum Ca2+-ATPase* , 1998, The Journal of Biological Chemistry.

[33]  K. Davies,et al.  Diaphragm rescue alone prevents heart dysfunction in dystrophic mice. , 2011, Human molecular genetics.

[34]  G. V. Ommen,et al.  Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains , 2012, Neuromuscular Disorders.

[35]  J. Ervasti,et al.  Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle , 1992, Nature.

[36]  Dmitry Akhmedov,et al.  The effects of obesity on skeletal muscle regeneration , 2013, Front. Physiol..

[37]  Jonathan P. Davis,et al.  The Positive Inotropic Effect of Pyruvate Involves an Increase in Myofilament Calcium Sensitivity , 2013, PloS one.

[38]  J. Marini,et al.  Dystropathology Increases Energy Expenditure and Protein Turnover in the Mdx Mouse Model of Duchenne Muscular Dystrophy , 2014, PloS one.

[39]  Michael P. Siegel,et al.  Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition. , 2013, Human molecular genetics.

[40]  M. Grounds,et al.  Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies , 2013, The FEBS journal.

[41]  H. Blau,et al.  Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy , 1988, Cell.

[42]  K. Campbell,et al.  mdx muscle pathology is independent of nNOS perturbation. , 1998, Human molecular genetics.

[43]  C. Ward,et al.  Measuring mitochondrial respiration in intact single muscle fibers. , 2012, American journal of physiology. Regulatory, integrative and comparative physiology.

[44]  O. H. Lowry,et al.  Effect of Duchenne muscular dystrophy on enzymes of energy metabolism in individual muscle fibers. , 1987, Metabolism: clinical and experimental.

[45]  R. Balaban,et al.  Effect of calcium on the oxidative phosphorylation cascade in skeletal muscle mitochondria. , 2013, Biochemistry.

[46]  J. Gillis,et al.  Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of some limb and respiratory muscles of the mouse , 1998, Neuromuscular Disorders.

[47]  K. Davies,et al.  Dystrophin and utrophin influence fiber type composition and post-synaptic membrane structure. , 2000, Human molecular genetics.

[48]  J. Faulkner,et al.  Contractile properties of skeletal muscles from young, adult and aged mice. , 1988, The Journal of physiology.

[49]  G. Radda,et al.  Exercise metabolism in Duchenne muscular dystrophy: a biochemical and [31P]-nuclear magnetic resonance study of mdx mice , 1993, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[50]  R. Koopman,et al.  A metabolic link to skeletal muscle wasting and regeneration , 2014, Front. Physiol..

[51]  Susan C. Brown,et al.  Utrophin-Dystrophin-Deficient Mice as a Model for Duchenne Muscular Dystrophy , 1997, Cell.

[52]  O. Shirihai,et al.  Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. , 2013, Cell metabolism.

[53]  G. Lynch,et al.  Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology. , 2010, The American journal of pathology.

[54]  A. Emery.  Muscular dystrophy--the facts. , 1994, Neuromuscular disorders : NMD.

[55]  M. Palacín,et al.  Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes. , 2010, Biochimica et biophysica acta.

[56]  M. Abdellatif,et al.  Endogenous Drp1 Mediates Mitochondrial Autophagy and Protects the Heart Against Energy Stress , 2015, Circulation research.

[57]  E. Homsher,et al.  Kinetics of force generation and phosphate release in skinned rabbit soleus muscle fibers. , 1992, The American journal of physiology.

[58]  E. Ravussin,et al.  Whole-body energy metabolism and skeletal muscle biochemical characteristics. , 1994, Metabolism: clinical and experimental.

[59]  S. Scherer,et al.  Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease. , 1997, Genomics.

[60]  K. Dietzmann,et al.  Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse , 1998, Molecular and Cellular Biochemistry.

[61]  P. Even,et al.  Dystrophin-dependent efficiency of metabolic pathways in mouse skeletal muscles , 1994, Experientia.

[62]  E. Hoffman,et al.  Metabolic remodeling agents show beneficial effects in the dystrophin- deficient mdx mouse model , 2012, Skeletal Muscle.

[63]  J. Eibl,et al.  Ca2+/calmodulin-based signalling in the regulation of the muscle fibre phenotype and its therapeutic potential via modulation of utrophin A and myostatin expression. , 2007, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.